ASSET PURCHASE AGREEMENT BY AND BETWEEN DR. REDDY’S LABORATORIES S.A., AS SELLER AND CITIUS PHARMACEUTICALS, INC., AS PURCHASER DATED AS OF September 1, 2021Asset Purchase Agreement • November 13th, 2023 • TenX Keane Acquisition • Blank checks • Delaware
Contract Type FiledNovember 13th, 2023 Company Industry JurisdictionThis Asset Purchase Agreement (this “Agreement”) dated as of September 1, 2021 (the “Effective Date”) by and between Dr. Reddy’s Laboratories S.A., a company incorporated under the laws of Switzerland and having its principal place of business located at Elisabethenanlage 11, CH - 4051, Basel, Switzerland (the “Seller”) and Citius Pharmaceuticals, Inc., a Nevada corporation having its principal place of business located at 11 Commerce Drive, First Floor, Cranford, New Jersey 07016 (the “Purchaser”). The Seller and the Purchaser may be collectively referred to herein as the “Parties” and each, individually, as a “Party”.
ConfidentialAsset Purchase Agreement • August 4th, 2021 • Biodelivery Sciences International Inc • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 4th, 2021 Company Industry Jurisdiction[***] Certain portions of this exhibit have been omitted because they are not material and the registrant customarily and actually treats that information as private or confidential.